METHAZOLAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methazolamide, and what generic alternatives are available?
Methazolamide is a drug marketed by Ani Pharms, Applied Anal, Athem, Bausch And Lomb Inc, Mikart, Sandoz, and Tagi. and is included in seven NDAs.
The generic ingredient in METHAZOLAMIDE is methazolamide. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methazolamide
A generic version of METHAZOLAMIDE was approved as methazolamide by ANI PHARMS on June 30th, 1993.
Summary for METHAZOLAMIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 9 |
Patent Applications: | 4,099 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for METHAZOLAMIDE |
DailyMed Link: | METHAZOLAMIDE at DailyMed |
Recent Clinical Trials for METHAZOLAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wilderness Medical Society | Phase 4 |
University of Waterloo | Phase 4 |
University of British Columbia | Phase 4 |